Global Prostate Biopsy Needle Market: Brief Account
The global prostate biopsy needle market
is anticipated to gain momentum with rising prevalence of prostate
cancer, which after skin cancer is researched to be the second most
common type of the disease occurring in men, mostly over 50 years of
age. Another disorder related to the prostate gland, i.e. benign
prostatic hyperplasia (BPH) is observed to be on the rise. Here, the
disorder causes enlargement of the gland. Rising prevalence of these
diseases is foreseen to significantly up the demand for prostate biopsy
needle. Among other prostate biopsy devices, needles could rake in a
higher demand in the coming years.
The report presented herewith is a
detailed account of key growth factors, trends and opportunities, and
other dynamics of the global prostate biopsy needle market. It is
compiled with the use of modern primary and secondary research
techniques for providing accurate statistics and latest data to the
readers.
Global Prostate Biopsy Needle Market: Trends and Opportunities
Frequent use of prostate biopsy needle in
the diagnosis and treatment of prostate-related diseases is foretold to
set the tone for a valuable rise in market growth. One of the most
commonly performed biopsies is researched to be transrectal ultrasound
(TRUS)-guided systematic needle biopsy. It is used as a standard
technique to detect prostate cancer. Usage of prostate biopsy needle
offers minimal morbidity, reduced contamination, decreased cost, and
greater convenience and is less complex.
Global Prostate Biopsy Needle Market: Geographical Analysis
Owing to increasing incidence of prostate
and bladder problems and sedentary lifestyle observed in the U.S.,
North America is prognosticated to achieve a king’s share of the
international prostate biopsy needle market in the coming years.
Moreover, availability of promising medical measures and greater
affordability to cover medical expenses could help the region to
maintain its position in the market. Development of new biopsy devices
is expected to stand out as another factor augmenting the demand in the
regional market.
Asia Pacific is envisioned to show
impressive growth while riding on rising government initiatives and
healthcare expenditure, improving healthcare infrastructure, large
population base, and surging incidence of cancer.
The international prostate biopsy needle
market marks the presence of prominent companies including Protek
Medical Products, PURE Medical Device, Cook Medical, Coloplast, and Bard
Medical. Players are foretold to compete on the basis of variety,
brand, availability, and price. They could focus on reviving domestic
demand and expanding their regional presence to gain a foothold in the
market.
No comments:
Post a Comment